Arie Kappetein

Showing 1-20 of 55 articles

Coronary interventions

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hara H, Kawashima H, Ono M, Takahashi K, Mack M, Holmes D, Morice M, Davierwala P, Mohr F, Thuijs D, Kappetein A, O'Leary N, van Klaveren D, Onuma Y, Serruys P

October 21, 2021 | 10.4244/EIJ-D-21-00415

Geographical variations in left main coronary artery revascularisation: a pre-specified analysis of the EXCEL trial

Myat A, Hildick-Smith D, de Belder A, Trivedi U, Crowley A, Morice M, Kandzari D, Lembo N, Brown W, Serruys P, Kappetein A, Sabik J, Stone G

July 2, 2021 | 10.4244/EIJ-D-21-00338

Coronary interventions

Impact of the CABG SYNTAX score on all-cause death at 10 years: a SYNTAX Extended Survival (SYNTAXES) substudy

Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein A, Head S, Onuma Y, Serruys P

May 16, 2021 | 10.4244/EIJ-D-20-00170

Coronary interventions

Procedural characteristics and clinical outcomes in patients undergoing percutaneous coronary intervention for left main trifurcation disease: the EXCEL trial

Kandzari D, Gershlick A, Serruys P, Leon M, Morice M, Simonton C, Lembo N, Mansour S, Sabaté M, Sabik J, Kappetein A, Dressler O, Stone G

December 18, 2020 | 10.4244/EIJ-D-19-00686

Coronary interventions

Influence of final kissing balloon inflation on long-term outcomes after PCI of distal left main bifurcation lesions in the EXCEL trial

Kini A, Dangas G, Baber U, Vengrenyuk Y, Kandzari D, Leon M, Morice M, Serruys P, Kappetein A, Sabik J, Dressler O, Mehran R, Sharma S, Stone G

June 25, 2020 | 10.4244/EIJ-D-19-00851

Coronary interventions

Prognostic performance of the Society of Thoracic Surgeons risk score in patients with left main coronary artery disease undergoing revascularisation: a post hoc analysis of the EXCEL trial

Thuijs D, Habib R, Head S, Puskas J, Taggart D, Stone G, Zhang Z, Serruys P, Sabik J, Kappetein A

May 20, 2020 | 10.4244/EIJ-D-19-00417

Does an occluded RCA affect prognosis in patients undergoing PCI or CABG for left main coronary artery disease? Analysis from the EXCEL trial

Chen S, Karmpaliotis D, Redfors B, Shlofmitz E, Ben-Yehuda O, Crowley A, Mehdipoor G, Puskas J, Kandzari D, Banning A, Morice M, Taggart D, Sabik J, Serruys P, Kappetein A, Stone G

August 9, 2019 | 10.4244/EIJ-D-19-00263

Coronary interventions

Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial

Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice M, Leon M, Kandzari D, Mehran R, Lembo N, Banning A, Merkely B, Kappetein A, Sabik J, Serruys P, Stone G

November 20, 2018 | 10.4244/EIJ-D-18-00711

Interventions for valvular disease

One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial

Serruys P, Modolo R, Reardon M, Miyazaki Y, Windecker S, Popma J, Chang Y, Kleiman NS, Lilly S, Amrane H, Boonstra P, Kappetein A, Onuma Y, Søndergaard L, Van Mieghem N

October 19, 2018 | 10.4244/EIJ-D-18-00460

Stable CAD

The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial

Milojevic M, Head S, Mack M, Mohr F, Morice M, Dawkins K, Holmes D, Serruys P, Kappetein A

May 20, 2018 | 10.4244/EIJ-D-17-00620

Coronary interventions

Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?

Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein A, Mohr F, Colombo A, Feldman T, Morice M

September 20, 2017 | 10.4244/EIJ-D-16-00991

Interventions for valvular disease

How should I treat an Edwards SAPIEN 3 aortic valve embolisation during a transaortic transcatheter aortic valve implantation?

Fournier S, Monney P, Roguelov C, Ferrari E, Eeckhout E, Mueller O, Durko A, Van Mieghem N, Kappetein A, Margey R

July 20, 2017 | 10.4244/EIJ-D-16-00592

Interventions for valvular disease

A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team

Amrane H, Porta F, Van Boven A, Kappetein A, Head S

June 2, 2017 | 10.4244/EIJ-D-16-00103

Coronary interventions

Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial

Milojevic M, Head S, Andrinopoulou E, Serruys P, Mohr F, Tijssen J, Kappetein A

May 15, 2017 | 10.4244/EIJ-D-16-00745

Coronary interventions

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Kappetein A, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G

September 18, 2016 | 10.4244/EIJV12I7A141

Interventions for valvular disease

Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve

Sawaya F, Kappetein A, Wisser W, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Wimmer-Greinecker G, Serruys P, Lefèvre T

August 20, 2016

Interventions for valvular disease

VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies

Erlebach M, Head S, Mylotte D, Leon M, Serruys P, Kappetein A, Martucci G, Généreux P, Windecker S, Lange R, Piazza N

June 20, 2016 | 10.4244/EIJV12I3A60

Coronary interventions

Rationale and design of the SYNTAX II trial evaluating the short to long-term outcomes of state-of-the-art percutaneous coronary revascularisation in patients with de novo three-vessel disease

Escaned J, Banning A, Farooq V, Echavarría-Pinto M, Onuma Y, Ryan N, Cavalcante R, Campos C, Stanetic B, Ishibashi Y, Suwannasom P, Kappetein A, Taggart D, Morel M, Van Es G-A, Serruys P

June 10, 2016 | 10.4244/EIJV12I2A36

Interventions for valvular disease

Current decision making and short-term outcome in patients with degenerative aortic stenosis: the Pooled-RotterdAm-Milano-Toulouse In Collaboration Aortic Stenosis survey

Van Mieghem N, Dumonteil N, Chieffo A, Roux Y, van der Boon R, Giustino G, Hartman E, Aga Y, de Jong L, Ghanem M, Marcheix B, Cavazza C, Carrié D, Colombo A, Kappetein A, de Jaegere P, Tchétché D

February 12, 2016 | 10.4244/EIJV11I10A253

Interventions for valvular disease

Measuring risk in valvular interventions: from low risk to futility

Kappetein A

September 17, 2015 | 10.4244/EIJV11SWA6

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

Transcatheter Paravalvular Leak Closure: Catch Me If You Can

Thomas Pilgrim et al.

October 20, 2021

STATE OF THE ART

Glucose-Lowering Therapy in Patients undergoing Percutaneous Coronary Intervention

Isabelle Johansson et al.